Tiffany Wilson

Tiffany has spent over 20 years bringing innovative medical technology from bench to bedside and is known globally for her thought leadership on innovation and commercialization in life sciences and healthcare technology.

In October 2020, she was appointed President and CEO of the Philadelphia-based University City Science Center to lead the organization’s next chapter focused on delivering economic, scientific, and civic impact. Operating at the intersection of startups, healthcare, and community, the Science Center drives inclusive economic growth across Greater Philadelphia and advances best-in-class healthcare solutions for all. 

Tiffany joined the Science Center from the Global Center for Medical Innovation (GCMI) based in Atlanta where she was CEO. After a decade working in strategy, finance and business development in early-stage medical device companies, she was brought onboard to launch and operationalize GCMI in 2011. During her tenure, she catalyzed a capital efficient approach to move innovation to products that impact patient outcomes, bringing critical assets, infrastructure, and expertise needed to support entrepreneurs from concept through testing, regulatory submission and launch. Her work in building and strengthening the medical device ecosystem in Atlanta and the Southeast US was formally recognized by both Georgia Bio and Southeast Life Sciences.

Tiffany joined GCMI from Atlanta-based Scientific Intake where she served as Vice President of Business Development and Strategy, focusing primarily on the evaluation and piloting of global distribution channels and product development for the global obesity market. Prior to Scientific Intake, she was Vice President of Corporate Strategy and Finance at ACell, a regenerative medicine and tissue engineering company that was acquired by Integra Lifesciences in 2020. At ACell, she led a broad range of initiatives, including corporate finance, investor relations, strategic and operational planning, business development, regulatory affairs, and reimbursement.

Tiffany began her career in management consulting and investment banking in the fintech industry where she developed a strong foundation in strategic, market, and financial analysis, M&A due diligence, and transaction structuring.

Tiffany serves on the Team Pennsylvania Board of Directors, the Chamber of Commerce for Greater Philadelphia Board of Directors, the Penn Health-Tech Strategic Advisory Board, the Drexel Applied Innovation External Advisory Board, and as an external advisor to the RADx program at the NIH. She served on the National Advisory Council on Innovation and Entrepreneurship (NACIE) of the U.S. Department of Commerce from 2014-2018. She was recognized by Philadelphia Business Journal in the Power 100 List in 2021 and 2022, Philadelphia Magazine’s “The 150 Most Influential Philadelphians 2023,” the Healthcare Technology Report’s Top 50 Healthcare Technology CEOs of 2021, Inc. Magazine as one of “17 Inspiring Women to Watch in 2017” and one of Becker Hospital Reviews “110 Women in Medtech to Know in 2017”. 

Tiffany holds an MBA from the Georgetown University McDonough School of Business and a BBA in International Business from Loyola University New Orleans.